Strategies of adoptive T -cell transfer to treat refractory viral infections post allogeneic stem cell transplantation

Virus-Specific T Cells: Broadening Applicability

(2018) A. John Barrett et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Early Experience With CliniMACS Prodigy CCS (IFN-gamma) System in Selection of Virus-specific T Cells From Third-party Donors for Pediatric Patients With Severe Viral Infections After Hematopoietic Stem Cell Transplantation

(2018) Krisztián Kállay et al.   JOURNAL OF IMMUNOTHERAPY

Establishment and Operation of a Third-Party Virus-Specific T Cell Bank within an Allogeneic Stem Cell Transplant Program

(2018) Barbara Withers et al.   BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION

Update on posttransplant lymphoproliferative disease

(2018) Paloma L. Martin-Moreno et al.   CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION

Immunotherapy for transplantation-associated viral infections

(2017) Claire Roddie et al.   JOURNAL OF CLINICAL INVESTIGATION

Cytomegalovirus-Specific T-Cell Transfer for Refractory Cytomegalovirus Infection After Haploidentical Stem Cell Transplantation: The Quantitative and Qualitative Immune Recovery for Cytomegalovirus

(2017) Xu-Ying Pei et al.   JOURNAL OF INFECTIOUS DISEASES

Transfer of minimally manipulated CMV-specific T cells from stem cell or third-party donors to treat CMV infection after allo-HSCT

(2017) M Neuenhahn et al.   LEUKEMIA

Response to antiviral therapy in haematopoietic stem cell transplant recipients with cytomegalovirus (CMV) reactivation according to the donor CMV serological status

(2016) S. Servais et al.   CLINICAL MICROBIOLOGY AND INFECTION

Adoptive T-cell therapy with hexon-specific Th1 cells as a treatment of refractory adenovirus infection after HSCT

(2015) J. Feucht et al.   BLOOD

T-cell Therapy Using a Bank of EBV-specific Cytotoxic T Cells

(2014) Géraldine Gallot et al.   JOURNAL OF IMMUNOTHERAPY

First-in-Man Clinical Results With Good Manufacturing Practice (GMP)-compliant Polypeptide-expanded Adenovirus-specific T Cells After Haploidentical Hematopoietic Stem Cell Transplantation

(2014) René Geyeregger et al.   JOURNAL OF IMMUNOTHERAPY

Donor-derived CMV-specific T cells reduce the requirement for CMV-directed pharmacotherapy after allogeneic stem cell transplantation

(2013) E. Blyth et al.   BLOOD

Interferon-γ capture T cell therapy for persistent Adenoviraemia following allogeneic haematopoietic stem cell transplantation

(2013) Waseem Qasim et al.   BRITISH JOURNAL OF HAEMATOLOGY

Safety and clinical efficacy of rapidly-generated trivirus-directed T cells as treatment for adenovirus, EBV, and CMV infections after allogeneic hematopoietic stem cell transplant

(2013) Ulrike Gerdemann et al.   MOLECULAR THERAPY

Rapid Salvage Treatment With Virus-Specific T Cells for Therapy-Resistant Disease

(2012) M. Uhlin et al.   CLINICAL INFECTIOUS DISEASES

Adoptive Transfer of Epstein-Barr Virus (EBV) Nuclear Antigen 1–Specific T Cells As Treatment for EBV Reactivation and Lymphoproliferative Disorders After Allogeneic Stem-Cell Transplantation

(2012) Vanya Icheva et al.   JOURNAL OF CLINICAL ONCOLOGY

Effective Treatment of Refractory CMV Reactivation After Allogeneic Stem Cell Transplantation With In Vitro-generated CMV pp65-specific CD8+ T-cell Lines

(2012) Pauline Meij et al.   JOURNAL OF IMMUNOTHERAPY

Adoptive immunotherapy with unselected or EBV-specific T cells for biopsy-proven EBV+ lymphomas after allogeneic hematopoietic cell transplantation

(2011) E. Doubrovina et al.   BLOOD

Generation of a multipathogen-specific T-cell product for adoptive immunotherapy based on activation-dependent expression of CD154

(2011) N. Khanna et al.   BLOOD

Simultaneous Isolation of CD8+ and CD4+ T Cells Specific for Multiple Viruses for Broad Antiviral Immune Reconstitution After Allogeneic Stem Cell Transplantation

(2011) Maarten L. Zandvliet et al.   JOURNAL OF IMMUNOTHERAPY

Effective and long-term control of EBV PTLD after transfer of peptide-selected T cells

(2010) A. Moosmann et al.   BLOOD

Adoptive transfer of pp65-specific T cells for the treatment of chemorefractory cytomegalovirus disease or reactivation after haploidentical and matched unrelated stem cell transplantation

(2010) T. Feuchtinger et al.   BLOOD

Directly Selected Cytomegalovirus-Reactive Donor T Cells Confer Rapid and Safe Systemic Reconstitution of Virus-Specific Immunity Following Stem Cell Transplantation

(2010) K. S. Peggs et al.   CLINICAL INFECTIOUS DISEASES

Challenges of T cell therapies for virus-associated diseases after hematopoietic stem cell transplantation

(2010) Ann M Leen et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

T Cells Engineered with a Cytomegalovirus-Specific Chimeric Immunoreceptor

(2010) F. Full et al.   JOURNAL OF VIROLOGY

Immune reconstitution after haploidentical hematopoietic cell transplantation: impact of reduced intensity conditioning and CD3/CD19 depleted grafts

(2010) B Federmann et al.   LEUKEMIA

Adoptive transfer and selective reconstitution of streptamer-selected cytomegalovirus-specific CD8+ T cells leads to virus clearance in patients after allogeneic peripheral blood stem cell transplantation

(2010) Anita Schmitt et al.   TRANSFUSION

Cytotoxic T lymphocyte therapy with donor T cells prevents and treats adenovirus and Epstein-Barr virus infections after haploidentical and matched unrelated stem cell transplantation

(2009) A. M. Leen et al.   BLOOD

How I treat EBV lymphoproliferation

(2009) H. E. Heslop   BLOOD

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

(2009) H. E. Heslop et al.   BLOOD

A novel haplo-identical adoptive CTL therapy as a treatment for EBV-associated lymphoma after stem cell transplantation

(2009) Michael Uhlin et al.   CANCER IMMUNOLOGY IMMUNOTHERAPY

Exploiting Cytokine Secretion to Rapidly Produce Multivirus-specific T Cells for Adoptive Immunotherapy

(2009) Yuriko Fujita et al.   JOURNAL OF IMMUNOTHERAPY